[Remantadine and 4-iodoantipyrine in the treatment and prevention of experimental influenza infection].
Evstropov
A N
AN
Iavorovskaia
V E
VE
Galegov
G A
GA
D000218:Adamantane / Q000031:analogs & derivatives*; D000818:Animals; D000983:Antipyrine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006389:Hemagglutinins, Viral / Q000097:blood; D009980:Influenza A virus / Q000276:immunology; D007372:Interferons / Q000097:blood; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D012299:Rimantadine / Q000008:administration & dosage / Q000627:therapeutic use*
D006389:Hemagglutinins, Viral; D012299:Rimantadine; D007372:Interferons; D000218:Adamantane; D000983:Antipyrine; C008135:iodoantipyrine
Kombinatsiia remantadina i 4-ĭodantipirina dlia lecheniia i profilaktiki éksperimental'noĭ grippoznoĭ infektsii.